Ascendis Pharma A/S (ASND) vs Bio-Techne Corp (TECH)
- Ascendis Pharma A/S ASND 225.78 −0.37%
- Bio-Techne Corp TECH 72.54 +0.03%
Ascendis Pharma A/S and Bio-Techne Corp are both Biotechnology companies. Ascendis Pharma A/S is the larger, with a market value of $14.9B against $11.4B — 1.3× the size. Ascendis Pharma A/S trades at the lower P/E: 16.3× against 62.0×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against −0.38%. Ascendis Pharma A/S has the higher net margin (71.2% vs 15.0%) and the higher return on invested capital (15.1% vs 7.70%). Across the 22 metrics below, Ascendis Pharma A/S leads on 14 and Bio-Techne Corp on 8.
Valuation
Profitability
| Metric | ASND | TECH | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.26% | 65.77% | 65.16% |
| Operating margin | 24.84% | 20.73% | 0.00% |
| Net margin | 71.20% | 14.97% | 0.00% |
| Free cash flow margin | 31.97% | 21.66% | 0.00% |
| Return on equity | 118.44% | 9.03% | (56.36%) |
| Return on assets | 44.34% | 7.07% | (48.04%) |
| Return on invested capital | 15.07% | 7.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack